Skip to content
10-Q

Quarterly Report

Elevation Oncology, Inc.

0001558370-24-010952

← back to feed
Filed
Aug 6, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 2, 2024 59.11M sh
Shares Diluted Q2 2024 · Jun 30, 2024 54.58M sh
Shares Diluted Q2 2024 · Jun 30, 2024 50.98M sh
Shares Diluted Q2 2024 · Jun 30, 2023 27.58M sh
Shares Diluted Q2 2024 · Jun 30, 2023 25.61M sh
Stock Repurchased Q2 2024 · Jun 30, 2024 $42K
Stock Repurchased Q2 2024 · Jun 30, 2023 $19K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$17.78M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$30.64M
Long Term Debt Q2 2024 · Jun 30, 2024 $30.92M
Long Term Debt Q2 2024 · Dec 31, 2023 $30.14M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $59.45M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $49.26M
Stockholders Equity Q2 2024 · Jun 30, 2024 $80.92M
Stockholders Equity Q2 2024 · Mar 31, 2024 $75.82M
Stockholders Equity Q2 2024 · Dec 31, 2023 $54.81M
Stockholders Equity Q2 2024 · Jun 30, 2023 $72.18M
Stockholders Equity Q2 2024 · Mar 31, 2023 $33.76M
Stockholders Equity Q2 2024 · Dec 31, 2022 $49.03M
Current Liabilities Q2 2024 · Jun 30, 2024 $2.76M
Current Liabilities Q2 2024 · Dec 31, 2023 $4.15M
Total Liabilities Q2 2024 · Jun 30, 2024 $33.68M
Total Liabilities Q2 2024 · Dec 31, 2023 $34.28M
Current Assets Q2 2024 · Jun 30, 2024 $113.57M
Current Assets Q2 2024 · Dec 31, 2023 $87.96M
Total Assets Q2 2024 · Jun 30, 2024 $114.6M
Total Assets Q2 2024 · Dec 31, 2023 $89.09M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.19
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.42
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.37
Eps Diluted Q2 2024 · Jun 30, 2023 −$1.06
Eps Basic Q2 2024 · Jun 30, 2024 −$0.18
Eps Basic Q2 2024 · Jun 30, 2024 −$0.38
Eps Basic restated Q2 2024 · Jun 30, 2023 −$0.36
Eps Basic restated Q2 2024 · Jun 30, 2023 −$1.04
Sga Expense Q2 2024 · Jun 30, 2024 $4.41M
Sga Expense Q2 2024 · Jun 30, 2024 $8.27M
Sga Expense Q2 2024 · Jun 30, 2023 $3.81M
Sga Expense Q2 2024 · Jun 30, 2023 $8.15M
Rd Expense Q2 2024 · Jun 30, 2024 $6.55M
Rd Expense Q2 2024 · Jun 30, 2024 $12.56M
Rd Expense Q2 2024 · Jun 30, 2023 $6.03M
Rd Expense Q2 2024 · Jun 30, 2023 $13.32M
Net Income Q2 2024 · Jun 30, 2024 −$10.46M
Net Income Q2 2024 · Jun 30, 2024 −$21.17M
Net Income Q2 2024 · Jun 30, 2023 −$10.11M
Net Income Q2 2024 · Jun 30, 2023 −$27.17M
Operating Income Q2 2024 · Jun 30, 2024 −$10.96M
Operating Income Q2 2024 · Jun 30, 2024 −$20.83M
Operating Income Q2 2024 · Jun 30, 2023 −$9.83M
Operating Income Q2 2024 · Jun 30, 2023 −$26.58M